Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...

Helix BioPharma's financial results for the nine-month period ending April 30, 2026, show a reduced net loss and strengthened cash position, driven by a private placement, as the company prepares for ...

Several annual international climate reports released Tuesday indicate that relentless human-caused warming continued in 2025, especially in the oceans and at the poles. For the third year in a row, ...

Download rstudio download resources for the RStudio IDE, a powerful environment for coding in R, building scripts, managing projects, visualizing data, and creating reproducible reports. Explore ...

Helix BioPharma announced narrower net losses for the three- and nine-month periods ended April 30, 2026, and a significant cash increase to $2.8 million, driven by a private placement, as it advances ...

This exploratory analysis of KEYNOTE-564 looked at associations of baseline ctDNA metrics and ctDNA change from baseline to cycle 5 day 1 with DFS. In patients who received pembrolizumab, the median ...